Groowe Groowe / Newsroom / NVO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVO News

Novo-Nordisk A/S

AI Revolutionizes Cardiovascular Drug Development with $1.4+ Billion in Strategic Investments

globenewswire.com
NVO PFE AZN LLY NVS JNJ MRK SNY

One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics

prnewswire.com
NVO EOLS ABBV CNXU

Post-Bariatric Hypoglycemia Market to Register Stunning Growth at a 16.4% CAGR Through 2036 Owing to the Emergence of Novel Drug Classes Such as GLP-1 Receptor Antagonists, SGLT1 Inhibitors, CRH Inhibitors, and SSTR5 Agonists | DelveInsight

prnewswire.com
AMRX NVO AMGN REGN GSK SNY AZN PFE BMRA MRK

A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It

prnewswire.com
NVO ABBV CNXU LLY

Novo Nordisk A/S - share repurchase programme

globenewswire.com
NVO

Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent Member

businesswire.com
NVO ARGX

Parker Waichman LLP Files Lawsuits on behalf of Georgia and California Residents Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic

prnewswire.com
NVO

Shantha Biologics gibt Zusammenarbeit im Bereich der Abfüllung und Endverarbeitung von Karpulen bekannt

prnewswire.com
NVO

Shantha Biologics annonce un partenariat dans le domaine du remplissage et de la finition de cartouches

prnewswire.com
NVO

Novo Nordisk A/S - share repurchase programme

globenewswire.com
NVO